A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
NCT01881633 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2013-06-19
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of single dosing study with three ascending dose cohorts of ISU302 in healthy subjects.
Conditions
- Gaucher Disease
Interventions
- DRUG
-
ISU302
- DRUG
Sponsors & Collaborators
-
ISU Abxis Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
More Related Trials
-
Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Subjects After Subcutaneous Injection of TISA-818-Inj
NCT07337044 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers
NCT01922349 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
NCT02183545 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
NCT06081530 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants
NCT03228433 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers
NCT02746302 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730
NCT03054194 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants
NCT02471859 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.
NCT03542344 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration
NCT02083666 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants
NCT04231513 ·Status: COMPLETED ·Phase: PHASE1
-
BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
NCT01052506 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection
NCT07241923 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers
NCT00421226 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers
NCT02244203 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
NCT04086602 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.
NCT04808154 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
NCT06625541 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers
NCT06103877 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers
NCT02309762 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers
NCT01958060 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of IBI3032 in Healthy Participants
NCT07120425 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants
NCT03188783 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Tolerability and Pharmacokinetics of IBI112 in Healthy Subjects
NCT04511624 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers
NCT01570205 ·Status: COMPLETED ·Phase: PHASE1